| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.054 | 0.7 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |